Examining people across the spectrum of type 2 diabetes—from healthy to the full-blown disease—Joslin Diabetes Center scientists have found a molecular pathway that offers novel targets for drugs.
Latinos are twice as likely to develop diabetes as Caucasians, and half the Latinos born in the United States in this century are predicted to get the disease. Helping to meet this challenge, Joslin Diabetes Center’s Latino Diabetes Initiative—a comprehensive effort that combines clinical care, patient education, community outreach, research and healthcare team education—has upgraded its website with additional resources for Latinos with diabetes and their families in both English and Spanish.
Joslin Diabetes Center researchers have identified a key molecular player that contributes to the increased bleeding that hemorrhagic strokes may cause in people with diabetes.
A $3.2-million award will fund first steps for innovative web services and support other initiatives in diabetes care and research.
In a step toward novel weight-loss therapies, Joslin Diabetes Center scientists identify cells in mice that can be triggered to transform into energy-burning brown fat.
Joslin research could help to explain changes in brain function among people with diabetes—including greater risk of Alzheimer’s disease.
Joslin scientist is given highest honor bestowed by the United States government on science and engineering professionals in the early stages of their careers.
A donation from the Thomas J. Beatson, Jr. Foundation will broaden access to Joslin's care ambassadors program for youth newly diagnosed with diabetes.
Patient centers will bring advances in diabetes care to Southeast Texas.
Web site features trilingual support, interactive nutrition guides for Asian meals and other culturally relevant information.
Joslin scientists nail down proof that some people with type 1 diabetes of extreme duration retain active insulin-producing cells.
The Mustang, the car that "changed everything" in the automotive industry, will now contribute to finding a cure for diabetes.
Joslin research finds natural mechanisms in insulin-producing cells that may be enhanced to aid type 1 diabetes treatments.
Joslin scientists discover mechanism that lowers insulin secretion in type 2 diabetes.
Boston life sciences leader provides expertise to world’s leading diabetes research and clinical care organization.
Harvard affiliates aid in establishing a comprehensive program for diabetes care, management and research
Long suspected of worsening artery damage in patients with diabetes, insulin instead protects blood vessels, a new study by Joslin Diabetes Center scientists indicates.
Joslin scientists find surprising twist in PI 3-kinase molecule that may offer novel target for diabetes drugs.
Salsalate, an anti-inflammatory agent, shows encouraging results in preliminary trial led by Joslin Diabetes Center.
Finding by Joslin Diabetes Center scientists may aid in understanding how insulin production eventually goes wrong in type 2 diabetes.
New collaboration leverages Joslin’s deep clinical and research expertise and dLife’s community and lifestyle approach to managing diabetes.
Joslin Diabetes Center scientists uncover clues toward treating age-related conditions via the blood.
In people who put on a lot of weight, or whose bodies start developing the inability to use insulin effectively that leads toward type 2 diabetes, the pancreas typically ramps up its supply of insulin-generating “beta” cells. Researchers at Joslin Diabetes Center and their colleagues now have identified a cell-cycle protein that is essential for beta-cell replication to respond successfully to insulin resistance. The finding may point toward eventual therapies for preventing or treating type 2 diabetes.
Joslin scientists discover that high blood glucose levels damage a key enzyme that guards against oxidative stress in beta cells.
Brown fat finding is declared one of the most important scientific accomplishments of 2009.
Over time, patients with type 2 diabetes lose insulin-producing cells, a difficulty that aggravates their disease. Researchers at Joslin Diabetes Center now have identified a mechanism that triggers the problem, giving a chance to find targets for drugs to protect these crucial cells.
Joslin Diabetes Center scientists discover new route by which high blood glucose levels damage eyes.
Weight management underlies a successful new approach to type 2 diabetes care at Joslin Diabetes Center.
Researchers at the Joslin Diabetes Center have linked another gene to a rare form of diabetes, a finding that could prove beneficial to those with the more common type 2 diabetes.
Researchers at the Joslin Diabetes Center have for the first time linked high levels of glutamate "“ a neurotransmitter in the brain produced from glucose "“ in people with type 1 diabetes to symptoms of depression and lower levels of cognitive performance.
The Association for Research in Vision and Ophthalmology (ARVO) is honored to announce this year's inaugural class of distinguished Fellows. Lloyd Paul Aiello, M.D., PhD, head of the Joslin Section on Eye Research, was among the group of members recognized for their accomplishments, leadership and contributions to the Association.
Joslin Diabetes Center today announced that Enrique Caballero, M.D., director of Joslin's Latino Diabetes Initiative (LDI), has been named the 2009 recipient of the Bernardo Alberto Houssay Award.
Joslin Diabetes Center today announced the opening of the Joslin Diabetes Center Affiliate at the Dubai Health Authority (DHA).
Researchers at the Joslin Diabetes Center have demonstrated that adult humans still have a type of "good" fat previously believed to be present only in babies and children.
Researchers at the Joslin Diabetes Center have shown for the first time that insulin plays a key role in suppressing levels of glucagon, a hormone involved in carbohydrate metabolism and regulating blood glucose levels.
Joslin Diabetes Center today announced Richard R. Crater as chief financial officer. Crater brings to Joslin more than 30 years of experience, including positions as chief financial officer at New York University Medical Center and The Massachusetts General Hospital (MGH). In his new role, Crater will be responsible for overall financial management and operational planning at the Joslin.
Joslin Diabetes Center scientists have launched a national clinical trial to investigate whether salsalate, an anti-inflammatory drug used for years to manage arthritis, can reduce blood glucose levels in people with type 2 diabetes.
Joslin Diabetes Center today announced it has received a $1 million gift from the Thomas J. Beatson, Jr. Foundation to support type 1 diabetes research.
Three-quarters of youths with type 1 diabetes were found to have insufficient levels of vitamin D, according to a study by researchers at the Joslin Diabetes Center.
A new study led by researchers at the Joslin Diabetes Center and Harvard Medical School has found that a common genetic variant associated with an increased risk of coronary artery disease (CAD) in the general population is also linked to an even higher risk for people with diabetes, particularly those with poor glucose control.
Researchers at the Joslin Diabetes Center have shown that insulin-producing pancreatic beta cells can form after birth or after injury from progenitor cells within the pancreas that were not beta cells.
C. Ronald Kahn, M.D., Head of the Joslin Section on Obesity and Hormone Action and the Mary K. Iacocca Professor of Medicine at Harvard Medical School, has been named the first winner of the Manpei Suzuki International Prize for Diabetes Research.
Joslin Diabetes Center today announced it has received a three-year, $3 million grant from the Eli Lilly and Company Foundation to help fund studies that will investigate the underlying causes of obesity and insulin resistance "“ two leading risk factors for diabetes and heart disease.
Joslin Diabetes Center today announced the introduction of the Joslin Professional Education Consortium (JPEC), a unique, comprehensive, Web-based resource and community for primary care physicians (PCPs) focused on treating diabetes and its complications.
A study by researchers from the Joslin Diabetes Center has shown for the first time that more than half of patients with type 2 diabetes who enrolled in a novel short-term weight management program were able to maintain the weight loss they achieved during the program on their own long-term.
A study by researchers at the Joslin Diabetes Center has shown that a protein known for its role in inducing bone growth can also help promote the development of brown fat, a "good" fat that helps in the expenditure of energy and plays a role in fighting obesity.
Researchers at the Joslin Diabetes Center have demonstrated for the first time that transplanted muscle stem cells can both improve muscle function in animals with a form of muscular dystrophy and replenish the stem cell population for use in the repair of future muscle injuries.
A study by researchers at the Joslin Diabetes Center has shown that adherence to prescribed dietary recommendations is associated with better glucose control in children with type 1 diabetes.
Clinicians across America now have access to the knowledge and opinions of a renowned diabetes expert, thanks to a collaboration between Joslin Diabetes Center Epocrates Inc.
Scientists at the Joslin Diabetes Center in Boston have found that a defect in the beta cells that make and release insulin has implications for the failure of these cells and the development of type 2 diabetes.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right